Cargando…
Correction: UBE2T knockdown inhibits gastric cancer progression
Autores principales: | Luo, Changjiang, Yao, Yunyi, Yu, Zeyuan, Zhou, Huinian, Guo, Lingyun, Zhang, Junqiang, Cao, Hongtai, Zhang, Genyuan, Li, Yumin, Jiao, Zuoyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010628/ https://www.ncbi.nlm.nih.gov/pubmed/36913306 http://dx.doi.org/10.18632/oncotarget.28356 |
Ejemplares similares
-
UBE2T knockdown inhibits gastric cancer progression
por: Luo, Changjiang, et al.
Publicado: (2017) -
A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination
por: Yu, Zeyuan, et al.
Publicado: (2020) -
Pancreatic fistula after pancreatoduodenectomy due to compression of the superior mesenteric vessels: a case report
por: Yang, Hanteng, et al.
Publicado: (2020) -
Correction: Tumor-derived exosomes induce PD1(+) macrophage population in human gastric cancer that promotes disease progression
por: Wang, Furong, et al.
Publicado: (2022) -
Survival Benefit of Metformin Use for Pancreatic Cancer Patients Who Underwent Pancreatectomy: Results From a Meta-Analysis
por: Zhang, Junqiang, et al.
Publicado: (2020)